Reconsidering a Common Practice: In-Hospital Use of PPIs.
作者信息
Herzig Shoshana J, Nardino Robert J
机构信息
Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
出版信息
J Gen Intern Med. 2016 Apr;31(4):361-2. doi: 10.1007/s11606-015-3565-2.
Abstract
摘要
相似文献
1
Reconsidering a Common Practice: In-Hospital Use of PPIs.
J Gen Intern Med. 2016 Apr;31(4):361-2. doi: 10.1007/s11606-015-3565-2.
2
Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study.
Eur J Gen Pract. 2014 Sep;20(3):174-80. doi: 10.3109/13814788.2013.844787. Epub 2013 Nov 13.
3
Effects of proton pump inhibitor on outcomes of patients with severe acute pancreatitis based on a national administrative database.
Pancreatology. 2015 Sep-Oct;15(5):491-496. doi: 10.1016/j.pan.2015.07.006. Epub 2015 Aug 8.
4
The relationship among proton pump inhibitors, bone disease and fracture.
Expert Opin Drug Saf. 2011 Nov;10(6):901-12. doi: 10.1517/14740338.2011.586628. Epub 2011 May 20.
5
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
J Cardiovasc Med (Hagerstown). 2012 Dec;13(12):783-9. doi: 10.2459/JCM.0b013e3283416b6b.
6
Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards.
Eur J Gastroenterol Hepatol. 2008 Jul;20(7):608-12. doi: 10.1097/MEG.0b013e3282f52f95.
7
General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
BMC Fam Pract. 2016 May 28;17:57. doi: 10.1186/s12875-016-0460-9.
8
Repositioning of proton pump inhibitors in cancer therapy.
Cancer Chemother Pharmacol. 2017 Nov;80(5):925-937. doi: 10.1007/s00280-017-3426-2. Epub 2017 Aug 31.
9
Practical considerations in the management of proton-pump inhibitors.
Rev Esp Enferm Dig. 2016 Mar;108(3):145-53. doi: 10.17235/reed.2015.3812/2015.
10
Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.
J Pediatr. 2016 Jul;174:63-70.e3. doi: 10.1016/j.jpeds.2016.03.059. Epub 2016 Apr 27.
引用本文的文献
1
Empiricism as Change Agent.
J Gen Intern Med. 2016 Apr;31(4):359-60. doi: 10.1007/s11606-016-3595-4.
本文引用的文献
1
Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients.
J Gen Intern Med. 2016 Apr;31(4):364-71. doi: 10.1007/s11606-015-3536-7. Epub 2015 Nov 9.
2
Hospitalist and primary care physician perspectives on medication management of chronic conditions for hospitalized patients.
J Hosp Med. 2014 May;9(5):303-9. doi: 10.1002/jhm.2137. Epub 2014 Feb 24.
3
In-hospital medication reviews reduce unidentified drug-related problems.
Eur J Clin Pharmacol. 2013 Mar;69(3):647-55. doi: 10.1007/s00228-012-1368-5. Epub 2012 Sep 7.
4
Acid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.
Arch Intern Med. 2011 Jun 13;171(11):991-7. doi: 10.1001/archinternmed.2011.14. Epub 2011 Feb 14.
5
Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.
6
Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722.
7
Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Ann Intern Med. 2008 Sep 16;149(6):391-8. doi: 10.7326/0003-4819-149-6-200809160-00005.
8
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
Arch Intern Med. 2007 May 14;167(9):950-5. doi: 10.1001/archinte.167.9.950.
9
Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Cochrane Database Syst Rev. 2006 Jan 25(1):CD002094. doi: 10.1002/14651858.CD002094.pub3.
10
Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.
JAMA. 1996;275(4):308-14.
Zotero 插件